NYSE ARCA | ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 4.95% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.23% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 4.20% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 4.19% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 4.12% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 4.07% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.98% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
| PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.84% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.80% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 3.74% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 3.73% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 3.68% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.65% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 3.60% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.56% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 3.50% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.50% |
| PCRX | Pacira BioSciences, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 3.31% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.24% |